NIH Updates Testing, Treatment Guidelines During Cocirculation of Influenza and COVID-19

The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.

The National Institutes of Health (NIH) on October 22, 2020 made updates to its COVID-19 Treatment Guidelines that provide information for clinicians in communities where influenza viruses and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are cocirculating.

Titled Influenza and COVID-19, the new section in the guideline discusses:

  • Influenza vaccination for those with COVID-19
  • Clinical presentation similarities/differences between the 2 viruses
  • Potential for coinfection with influenza and SARS-CoV-2
  • Testing for influenza and SARS-CoV-2 in patients with acute respiratory symptoms
  • Treatment of influenza in the setting of cocirculatling SARS-CoV-2

Get a top-line review in the short slide show that follows.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
© 2023 MJH Life Sciences

All rights reserved.